Pentrexcilina
NDC Package 69729-155-06

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Pentrexcilina is adults and children 12 years of age and older: Take 2 tablets every 6 to 8 hours as needed, do not exceed 8 tablets in 24 hours, or as directed by a doctor. Marketed by Opmx Llc, this product is identified by NDC 69729-155 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
69729-155-06
Package Description
6 POUCH in 1 PACKAGE / 2 TABLET in 1 POUCH
Product Code
69729-155
11-Digit Billing Format
69729015506
RxNorm Crosswalk
  • RxCUI: 1367205 - acetaminophen 325 MG / dextromethorphan HBr 15 MG / phenylephrine HCl 5 MG Oral Tablet
  • RxCUI: 1367205 - acetaminophen 325 MG / dextromethorphan hydrobromide 15 MG / phenylephrine hydrochloride 5 MG Oral Tablet
  • RxCUI: 1367205 - APAP 325 MG / dextromethorphan hydrobromide 15 MG / phenylephrine hydrochloride 5 MG Oral Tablet

Clinical Specifications

Proprietary Name
Pentrexcilina
Dosage Form
-
Usage Information
Adults and children 12 years of age and older: Take 2 tablets every 6 to 8 hours as needed, do not exceed 8 tablets in 24 hours, or as directed by a doctor. Children under 12 years, consult a doctor

Regulatory & Marketing

Labeler Name
Opmx Llc
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
01-05-2018
Listing Expiration
12-31-2019
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (69729-155). Click a package code to view its specific billing and regulatory data.

69729-155-72
72 POUCH in 1 PACKAGE / 2 TABLET in 1 POUCH

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69729-155-06 identifies a specific commercial package of 6 pouch in 1 package / 2 tablet in 1 pouch of Pentrexcilina, labeled by Opmx Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Opmx Llc on January 05, 2018. The current certification is valid through December 31, 2019.

How is this Opmx Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69729015506. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69729-155-06
11-Digit CMS (5-4-2)
69729-0155-06

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.